Juan C. Quiros-De

Juan C. Quiros-De

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV.

Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 06, 2024

Contribution of Low CD4 Cell Counts and High Human Immunodeficiency Virus (HIV) Viral Load to the Efficacy of Preferred First-Line Antiretroviral Regimens for Treating HIV Infection: A Systematic Review and Meta-Analysis.

Contribution of Low CD4 Cell Counts and High Human Immunodeficiency Virus (HIV) Viral Load to the Efficacy of Preferred First-Line Antiretroviral Regimens for Treating HIV Infection: A Systematic Review and Meta-Analysis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 30, 2023

SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid.

SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid.

Journal: AIDS research and human retroviruses

Published: December 31, 2021

Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.

Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.

Journal: Expert review of clinical pharmacology

Published: January 27, 2021

Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.

Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.

Journal: BMC infectious diseases

Published: September 23, 2020

Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain.

Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain.

Journal: Clinical and experimental immunology

Published: July 25, 2020

Frailty, markers of immune activation and oxidative stress in HIV infected elderly.

Frailty, markers of immune activation and oxidative stress in HIV infected elderly.

Journal: PloS one

Published: January 04, 2020

Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B.

Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B.

Journal: Vaccines

Published: October 22, 2019

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients.

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients.

Journal: Open forum infectious diseases

Published: May 27, 2019

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

Journal: PloS one

Published: December 15, 2016

Frailty and physical function in older HIV-infected adults.

Frailty and physical function in older HIV-infected adults.

Journal: Age and ageing

Published: August 15, 2016

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Journal: Enfermedades infecciosas y microbiologia clinica

Published: February 03, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026